

It is given as an infusion into a vein over a period of time.Use Intralipid (fat emulsion (plant based)) as ordered by your doctor. How is this medicine (Intralipid) best taken? You will need to talk about any risks to your baby. Tell your doctor if you are breast-feeding.You will need to talk about the benefits and risks of using Intralipid (fat emulsion (plant based)) Tell your doctor if you are pregnant or plan on getting pregnant.The risk is also higher in premature infants. There is a chance of aluminum toxicity if you are on Intralipid (fat emulsion (plant based)) for a long time. Be sure your doctor and lab workers know you use Intralipid (fat emulsion (plant based)). This medicine may affect certain lab tests.Have blood work checked as you have been told by the doctor.This includes your doctors, nurses, pharmacists, and dentists. Tell all of your health care providers that you take Intralipid (fat emulsion (plant based)).What are some things I need to know or do while I take Intralipid? Do not start, stop, or change the dose ofĪny drug without checking with your doctor. To make sure that it is safe for you to take Intralipid (fat emulsion (plant based)) with all of your drugs and health problems. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems.

This is not a list of all drugs or health problems that interact with Intralipid (fat emulsion (plant based)). (lipoid nephrosis or minimal change disease).

The two combinations that met USP criteria for physical incompatibility were cisatracurium 2 mg/mL with Intralipid and gentamicin 2 mg/mL with Smoflipid. Incompatibilities differed for the different brands of lipid emulsion. Most combinations tested were physically compatible based on USP regulations. Physical compatibility was determined by measuring the percentage of fat residing in globules larger than 5 µm (PFAT5) per USP recommendations. Each sample was then diluted with particle-free water and analyzed using the analytical technique of light obscuration recommended in United States Pharmacopeia (USP) general information chapter 729 (USP ). Medications at commonly used pediatric concentrations were mixed in a 1:1 ratio with lipid emulsions (Intralipid, Nutrilipid, and Smoflipid) and incubated at room temperature for 4 hours to simulate Y-site administration. To determine the physical intravenous Y-site compatibility of 19 commonly used medications at pediatric concentrations with 3 different types of lipid emulsion.
